These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 30676179

  • 21. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.
    Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K.
    Radiat Res; 2012 Mar; 177(3):229-43. PubMed ID: 22171960
    [Abstract] [Full Text] [Related]

  • 22. Effects of radiation on the incidence of prostate cancer among Nagasaki atomic bomb survivors.
    Kondo H, Soda M, Mine M, Yokota K.
    Cancer Sci; 2013 Oct; 104(10):1368-71. PubMed ID: 23859763
    [Abstract] [Full Text] [Related]

  • 23. The grave is wide: the Hibakusha of Hiroshima and Nagasaki and the legacy of the Atomic Bomb Casualty Commission and the Radiation Effects Research Foundation.
    O'Malley GF.
    Clin Toxicol (Phila); 2016 Jul; 54(6):526-30. PubMed ID: 27158765
    [Abstract] [Full Text] [Related]

  • 24. Genetic effects of radiation in atomic-bomb survivors and their children: past, present and future.
    Nakamura N.
    J Radiat Res; 2006 Jul; 47 Suppl B():B67-73. PubMed ID: 17019054
    [Abstract] [Full Text] [Related]

  • 25. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer.
    Land CE.
    JAMA; 1995 Aug 02; 274(5):402-7. PubMed ID: 7616636
    [Abstract] [Full Text] [Related]

  • 26. The Atomic Bomb Casualty Commission in retrospect.
    Putnam FW.
    Proc Natl Acad Sci U S A; 1998 May 12; 95(10):5426-31. PubMed ID: 9576898
    [Abstract] [Full Text] [Related]

  • 27. Cardiovascular disease risk among atomic bomb survivors exposed in utero, 1978-2003.
    Tatsukawa Y, Nakashima E, Yamada M, Funamoto S, Hida A, Akahoshi M, Sakata R, Ross NP, Kasagi F, Fujiwara S, Shore RE.
    Radiat Res; 2008 Sep 12; 170(3):269-74. PubMed ID: 18763869
    [Abstract] [Full Text] [Related]

  • 28. Noncancer disease incidence in atomic bomb survivors, 1958-1998.
    Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G.
    Radiat Res; 2004 Jun 12; 161(6):622-32. PubMed ID: 15161358
    [Abstract] [Full Text] [Related]

  • 29. Risk of Prostate Cancer Incidence among Atomic Bomb Survivors: 1958-2009.
    Mabuchi K, Preston DL, Brenner AV, Sugiyama H, Utada M, Sakata R, Sadakane A, Grant EJ, French B, Cahoon EK, Ozasa K.
    Radiat Res; 2021 Jan 01; 195(1):66-76. PubMed ID: 33181833
    [Abstract] [Full Text] [Related]

  • 30. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Cancer risk among in utero-exposed survivors.
    Yoshimoto Y, Kato H, Schull WJ.
    J Radiat Res; 1991 Mar 01; 32 Suppl():231-8. PubMed ID: 1762110
    [Abstract] [Full Text] [Related]

  • 31. DS02R1: Improvements to Atomic Bomb Survivors' Input Data and Implementation of Dosimetry System 2002 (DS02) and Resulting Changes in Estimated Doses.
    Cullings HM, Grant EJ, Egbert SD, Watanabe T, Oda T, Nakamura F, Yamashita T, Fuchi H, Funamoto S, Marumo K, Sakata R, Kodama Y, Ozasa K, Kodama K.
    Health Phys; 2017 Jan 01; 112(1):56-97. PubMed ID: 27906788
    [Abstract] [Full Text] [Related]

  • 32. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K, Fujiwara S, Yamada M, Kasagi F, Shimizu Y, Shigematsu I.
    World Health Stat Q; 1996 Jan 01; 49(1):7-16. PubMed ID: 8896251
    [Abstract] [Full Text] [Related]

  • 33. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M, Ohishi W, Nakashima E, Sera N, Neriishi K, Yamada M, Tatsukawa Y, Takahashi I, Fujiwara S, Sugino K, Ando T, Usa T, Kawakami A, Akahoshi M, Hida A.
    J Clin Endocrinol Metab; 2017 Jul 01; 102(7):2516-2524. PubMed ID: 28472357
    [Abstract] [Full Text] [Related]

  • 34. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N, Satoh K, Otani K, Kawakami H, Ohtaki M.
    Hiroshima J Med Sci; 2016 Sep 01; 65(2):45-51. PubMed ID: 29989684
    [Abstract] [Full Text] [Related]

  • 35. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
    McCunney RJ, Li J.
    Chest; 2014 Mar 01; 145(3):618-24. PubMed ID: 24590022
    [Abstract] [Full Text] [Related]

  • 36. Exposure to ionizing radiation and brain cancer incidence: The Life Span Study cohort.
    Smoll NR, Brady Z, Scurrah K, Mathews JD.
    Cancer Epidemiol; 2016 Jun 01; 42():60-5. PubMed ID: 27038588
    [Abstract] [Full Text] [Related]

  • 37. Organ doses received by atomic bomb survivors during radiological examinations at the Radiation Effects Research Foundation.
    Kazuo K, Antoku S, Sawada S, Russell WJ.
    Br J Radiol; 1991 Aug 01; 64(764):720-7. PubMed ID: 1884121
    [Abstract] [Full Text] [Related]

  • 38. Radiation and cancer risk in atomic-bomb survivors.
    Kodama K, Ozasa K, Okubo T.
    J Radiol Prot; 2012 Mar 01; 32(1):N51-4. PubMed ID: 22394591
    [Abstract] [Full Text] [Related]

  • 39. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
    Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K.
    Radiat Res; 2003 Oct 01; 160(4):381-407. PubMed ID: 12968934
    [Abstract] [Full Text] [Related]

  • 40. The Effect of Prostate-Specific Antigen (PSA) Test on Radiation Risk Estimate for Prostate Cancer Incidence among Atomic-Bomb Survivors.
    Utada M, Brenner AV, Preston DL, Yamada M, Grant EJ, Sugiyama H, Sakata R, Cahoon EK, Ozasa K, Mabuchic K.
    Radiat Res; 2023 Jul 01; 200(1):96-101. PubMed ID: 37141253
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.